Results 71 to 80 of about 11,207 (204)

Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia

open access: yesCase Reports in Medicine, 2012
Rituximab-induced lung disease (R-ILD) is a rare entity that should be considered in patients treated with rituximab who present with dyspnea, fever, and cough, but no clear evidence of infection.
Ahmet B. Ergin, Nancy Fong, Hamed A. Daw
doaj   +1 more source

Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia

open access: yesCase Reports in Pulmonology, 2012
Introduction. Bortezomib is a proteasome inhibitor indicated for the treatment of multiple myeloma patients. The most frequent side effects are gastrointestinal and neurological. Serious pulmonary complications have been described rarely.
E. Vandeix   +5 more
doaj   +1 more source

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation [PDF]

open access: bronze, 1997
Timothy J. Kroshus   +5 more
openalex   +1 more source

Bronchiolitis Obliterans Organizing Pneumonia Associated with AcuteMycoplasma pneumoniaeInfection [PDF]

open access: bronze, 1997
Josep M. Llibre   +4 more
openalex   +1 more source

Bronchiolitis obliterans with organising pneumonia: outcome. [PDF]

open access: bronze, 1995
Ulrich Costabel   +2 more
openalex   +1 more source

Relationship between sleep quality and quality of life in chemical warfare victims with bronchiolitis obliterans referred to Baqiyatallah hospital of Tehran, Iran

open access: yesPayesh, 2011
Objective(s): Decrease of quality of life and undesirable sleep quality in individual with bronchiolitis due to chemical exposure reported in previous studies.
Sudabeh Mahdizadeh   +6 more
doaj  

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Swyer-James-Macleod Syndrome presentating as pneumothorax

open access: yesJournal of Pediatric Surgery Case Reports, 2018
Swyer-James-MacLeod Syndrome is a rare form of post-infectious bronchiolitis obliterans, characterized by unilateral lung hyperlucency due to loss of pulmonary vasculature and alveolar hyperdistention, in the absence of main bronchial obstruction.
Morgado Mariana   +4 more
doaj  

Home - About - Disclaimer - Privacy